Keep Klear

Pioneering Hygiene Solutions for Tomorrow

kk icon with text -01

Advancing Pathogen-Free Environments with Revolutionary Residual Microbicidal Coating Technology ​

The Rise of HAIs:
The Driving Forces You Need to Know

Hygiene Challenges: Issues like staff shortages, time pressures, cost concerns, miscommunications, and neglect, contribute to ineffective hygiene practices, emphasizing the role of surfaces in transmitting microbes

Surface slip-ups! Data regarding compliance with hygiene protocols for inanimate surfaces is notably limited, with findings suggesting a modest adherence rate of only 48%

Risk Amplification

Patients entering rooms previously occupied by individuals with multi-drug resistant bacterial infections face heightened risk of colonization and infection.

Healthcare Hygiene Importance​

Preventing Healthcare-Associated Infections (HAIs) is pivotal, and hygiene is the frontline defense​.

Pathogen Transmission

Within healthcare facilities, pathogens like VRE, Clostridium difficile, Acinetobacter spp., and MRSA can easily transfer from one surface to another.


Standard surface disinfectants can rapidly reduce microbe levels, but their effects fade after application, leaving surfaces vulnerable to recontamination

Keep Klear operates autonomously between standard disinfection cycles, continuously reducing microbial counts on coated surfaces and minimizing transmission risks.

Key Features

Industry-leading 7-day residual activity claim, a first for Canada

Based on US EPA MB-40-00 

Easy to apply, coating dries within
 10 mins
Forms ultra thin, transparent coating. Suitable for multiple hard surfaces
Non-toxic & Non-corrosive
Kills an array of drug resistant pathogens

Based on 3rd party lab based studies (JSZ2801 & MB-40-00) 

The coating can be removed.

Keep Klear vs CDC's list of
concerning pathogens

The U.S. Centers for Disease Control and Prevention (CDC) unveiled the 2019 AR Threats Report, a comprehensive 140-page public document offering a vivid depiction of the prevailing resistance crisis in the United States. This report stands as a monumental achievement, meticulously crafted by a dedicated team of CDC scientists and select external collaborators. Drawing upon their combined expertise in infectious diseases, microbiology, epidemiology, data science, and policy, the report provides a thorough and insightful analysis of the current landscape, shedding light on key challenges and guiding future strategies to combat antibiotic resistance.

Know More

Urgent Threats Keep Klear Efficacy#
Carbapenem-resistant Acinetobacter
Candida auris
Clostridioides difficile
Carbapenem-resistant Enterobacteriaceae
Drug-resistant Neisseria gonorrhoeae Serious Threats
Studies under progress

Keep Klear destroys
biofilms secreted by

Serious Threats Keep Klear Efficacy#
Drug-resistant Campylobacter
Drug-resistant Candida
ESBL-producing Enterobacteriaceae
Vancomycin-resistant Enterococci
Multidrug-resistant Pseudomonas aeruginosa
Drug-resistant nontyphoidal Salmonella
Drug-resistant Salmonella serotype Typhi
Drug-resistant Shigella Studies under progress
Studies under progress
Methicillin-resistant Staphylococcus aureus
Drug-resistant Streptococcus pneumoniae
Drug-resistant Tuberculosis Studies under progress

Disclaimer: The data presented above demonstrates the effectiveness of Keep Klear treated surfaces according to the JISZ2901 standard. However, it does not reflect the label claim issued by the PMRA

Safeguarding patients & staff

Reduce nosocomial infection

Reduce patient lengths of stay

Reduce patient readmission

Improve patient outcomes

Creating bio burden free & eventually infection free ICUs

Safeguarding operating theatres

Long-term strategy for reducing cost

Keep Klear technology overview

Join our journey to
strengthen IPAC